(Q39316343)

11 September 2017

title

Increased IL-13 but not IL-5 production by CD4-positive T cells and CD8-positive T cells in multiple sclerosis during relapse phase (English)

1 reference

11 September 2017

0 references

Hirofumi Ochi

1

1 reference

11 September 2017

Manabu Osoegawa

2

1 reference

11 September 2017

Xiao-Mu Wu

3

1 reference

11 September 2017

Motozumi Minohara

4

1 reference

11 September 2017

Izumi Horiuchi

5

1 reference

11 September 2017

Hiroyuki Murai

6

1 reference

11 September 2017

Hirokazu Furuya

7

1 reference

11 September 2017

Jun-ichi Kira

8

1 reference

11 September 2017

language of work or name

1 reference

1 September 2002

1 reference

Journal of the Neurological Sciences

11 September 2017

published in

1 reference

11 September 2017

volume

201

1 reference

11 September 2017

issue

1-2

1 reference

11 September 2017

page(s)

45-51

1 reference

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Functional diversity of helper T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Balancing the Th1/Th2 concept in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Detection of intracellular cytokines by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

The multiplex function of nitric oxide in (auto)immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

IL-4, IL-10 and IL-13 modulate A beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900189-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00189-2

1 reference

11 September 2017

1 reference